Approval · Notice of Compliance 9923 · 2008
SOLAGÉ: Notice of Compliance 9923
Issued December 4, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9923
- Date
- December 4, 2008
- Company
- Stiefel Canada UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Agent for the treatment of solar lentigines and related hyperpigmented lesions
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLAGÉ | 02243257 | Cancelled Post Market |